Work

A Phase I Study of Immune Checkpoint Inhibition (anti-CTLA4 and anti-PD-L1) in Combination with RadiationTherapy in Patients with Locally Advanced UnresectablePancreatic Cancer

FWCI: 0.08
Cites:
Cited by: 1
Related to: